Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eanas Yassa

Vascular Surgery Grand Rapids, MI Medical Doctor

NPI 1396954376 CMS profile 153868

275 Michigan St Ne, Grand Rapids, MI 49503

Open in the dashboard

General payments

$80,524

342 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$104,330 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Eanas Yassa of Grand Rapids, MI is reported in the CMS Open Payments database as having received $80,524 across 342 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $104,330 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,308 56
2024 General $21,848 69
2023 General $10,676 64
2022 General $5,605 51
2021 General $13,470 44
2020 General $13,778 21
2019 General $8,839 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eanas Yassa
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Eanas Yassa were reported at $6,308. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Eanas Yassa Vascular Surgery median Middle half National median
2019 $8,839 $796 $226–$2,363 $163
2020 $13,778 $348 $118–$1,110 $114
2021 $13,470 $471 $158–$1,421 $132
2022 $5,605 $725 $222–$2,183 $149
2023 $10,676 $836 $257–$2,440 $160
2024 $21,848 $909 $252–$2,619 $164
2025 $6,308 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cook Incorporated $39,913 26 payments
  2. W. L. Gore & Associates, Inc. $16,133 143 payments
  3. Cook Medical LLC $11,570 82 payments
  4. Wilson Cook Medical Incorporated $6,496 4 payments
  5. Shape Memory Medical Inc. $2,369 7 payments
  6. Penumbra, Inc. $891 9 payments
  7. Endologix, Inc. $677 11 payments
  8. Medtronic, Inc. $528 7 payments
  9. Kerecis Limited $280 5 payments
  10. Shockwave Medical, Inc $210 3 payments
  11. Other $1,457 45 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $26,745 10 payments
  2. Travel and Lodging $16,513 43 payments
  3. Consulting Fee $13,775 10 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $12,000 5 payments
  5. Food and Beverage $11,491 274 payments
Products named General payments · program years 2019–2025
  1. COOK $19,484 25 payments
  2. Cook Medical Zenith $10,307 14 payments
  3. GORE TAG Thoracic Branch Endoprosthesis $7,264 59 payments
  4. Cook Medical Thoracic $6,667 12 payments
  5. Zenith $6,269 15 payments
  6. ZENITH ALPHA Aortic Intervention $5,821 3 payments
  7. Product in Development $4,126 10 payments
  8. Zenith Alpha Aortic Intervention $3,897 16 payments
  9. IMPEDE EMBOLIZATION PLUG $2,369 7 payments
  10. GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis $1,824 13 payments
  11. Other $13,660 195 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

60

Median for Vascular Surgery: 122

Drug cost

$1,078

Median for Vascular Surgery: $14,135

Branded share of claims

71.7%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 43 $804
Cilostazol Generic 17 $275

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 87 billing codes

Paid by Medicare

$70,267

Medicare's payments for the services billed

Medicare patients

217

Average age 74

Services billed

424

91 women, 126 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 53%
Arthritis 48%
Diabetes 36%
Chronic kidney disease 36%
COPD 36%
Heart failure 31%
Atrial fibrillation 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

342 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record